The STAT-ON device is a holter providing continuous, personalized information about the motor status of people affected by this disease. Essential data and to adapt the treatment to each patient.

The lack of daily information on the clinical status of patients with Parkinson's disease was one of the biggest hurdles for neurologists when choosing a treatment. To reverse this situation, The STAT-ON device was born to monitor this disease.

This small sensor is placed in a specially designed belt for the patient. STAT-ON continuously records fluctuations ON / OFF people treated for a few years by levodopa, as well as the motivation of other motor symptoms of the affected person – radicinesia, dyskinesia and gait blockages – to adapt treatments and improve the quality of life of these people.

Patients with Parkinson's disease are currently receiving symptomatic treatment to compensate for the lack of certain neurotransmitters. After a few years, with clinical control with levodopa, appear fluctuations of 50% of those affected. Thus, motor symptoms of advanced Parkinson's disease fluctuate several times during the day, in connection with levodopa use. These fluctuations ON / OFF they cause serious difficulties for their clinical stability and control through medication.

Movements and falls

In this line, drugs do not only play an important role. The STAT-ON device is also able to record the parameters of the gait, falls and other characteristics of the movement of people, which help to better manage the disease.

"The measurements and data provided by this Holter for Parkinson's disease they will help doctors make informed decisions for optimized disease management. It should be noted that this device does not provide any type of diagnosis, but the information collected is of great value to health professionals, who can accurately determine the true health status of the affected person, explains Dr. Angels Bayés. , from the Parkinson Unit of the Teknon Medical Center – Quirónsalud group, which participated in the development of this new device.

However, we must take into account the characteristics of each patient: everyone does not move in the same way. Therefore, the Holter To do this, he uses the first data obtained from the person, "learns" his movements and, using artificial intelligence techniques, customizes the algorithms he uses to record his motor symptoms. . Once this step is over, the Holter It works autonomously and is very easy to use.

While the person is wearing it, It does not need any type of player or connection. "Since the device is not invasive, the patient can use it in his or her normal life, by carrying the sensor in a comfortable and discreet belt during Holter record the status of your engine at any time of the day. A report on the motor status of the affected person is then generated throughout the day, "says Joan Cabestany, telecommunications engineer, UPC researcher and expert in artificial intelligence and electronics applied to dependence and active aging.

The creation of this holter is fruit of a decade of research and the joint work of the Parkinson's Unit of the Teknon – Quirónsalud Medical Center and the Polytechnic University of Catalonia (UPC) – and BarcelonaTech – through the Center for Technological Studies for the Treatment of dependence (CETpD) -. For its part, Sense4Care, spin-off of the UPC, has made the final development of the scheme, for which partial EU funding has been granted as part of a project for small and medium-sized enterprises (SME Instruments).

Increase in the incidence of Parkinson's disease

The incidence of Parkinson's disease has increased in recent years largely due to the increase in life expectancy of the population. More than seven million people worldwide have already been diagnosed with this disease. neurodegenerative disorder, of which 1.5 million live in Europe and 150,000 in Spain.

This disease causes severe motor problems throughout the course of life and can lead to movement blockages, as well as hidden non-motor symptoms such as pain, apathy, confusion, difficulty speaking, sleep disturbance, and depression. According to data from the Spanish Society of Neurology, 10,000 new cases of Parkinson's are diagnosed each year and this is the second most common neurodegenerative pathology after Alzheimer's disease.

Leave a Reply

Your email address will not be published. Required fields are marked *